A9855-2011 Actions

• May 23, 2012: REFERRED TO HEALTH
• May 23, 2012: delivered to senate
• May 23, 2012: passed assembly
• May 22, 2012: ordered to third reading rules cal.35
• May 22, 2012: rules report cal.35
• May 22, 2012: reported
• May 22, 2012: reported referred to rules
• May 22, 2012: reported referred to codes
• May 3, 2012: print number 9855a
• May 3, 2012: amend (t) and recommit to health
• Apr 18, 2012: referred to health

A9855-2011 Text

 S T A T E   O F   N E W   Y O R K
 
 
                                         9855
 I N  ASSEMBLY
 April 18, 2012
 
 Introduced  by  M.  of A. ZEBROWSKI, CUSICK -- read once and referred to
 the Committee on Health
 

AN ACT to amend the public health law, in relation to adding  cannabimi
 metic agents to the schedule of controlled substances
 

THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM
 BLY, DO ENACT AS FOLLOWS:

 

Section 1. Schedule I of section 3306 of  the  public  health  law  is
 amended by adding a new subdivision (g) to read as follows:

 (G)  CANNABIMIMETIC  AGENTS.  UNLESS  SPECIFICALLY  EXEMPTED OR UNLESS
 LISTED IN ANOTHER SCHEDULE, ANY MATERIAL, COMPOUND, MIXTURE, OR PREPARA
 TION WHICH CONTAINS ANY QUANTITY OF CANNABIMIMETIC AGENTS, THEIR  SALTS,
 ISOMERS,  AND  SALTS  OF  ISOMERS  WHENEVER THE EXISTENCE OF SUCH SALTS,
 ISOMERS, AND SALTS OF ISOMERS ARE POSSIBLE WITHIN THE SPECIFIC  CHEMICAL
 DESIGNATION:

 (1)  CANNABIMIMETIC  AGENTS  MEANS ANY SUBSTANCE THAT IS A CANNABINOID
 RECEPTOR TYPE 1  (CB1  RECEPTOR)  AGONIST  AS  DEMONSTRATED  BY  BINDING
 STUDIES AND FUNCTIONAL ASSAYS WITHIN THE FOLLOWING STRUCTURAL CLASSES:

 (I)  2-(3-HYDROXYCYCLOHEXYL)PHENOL WITH SUBSTITUTION AT THE 5-POSITION
 OF THE PHENOLIC RING BY ALKYL OR ALKENYL, WHETHER OR NOT SUBSTITUTED  ON
 THE CYCLOHEXYL RING TO ANY EXTENT.
 (II)  3-(1-NAPHTHOYL)INDOLE OR 3-(1-NAPHTHYL)INDOLE BY SUBSTITUTION AT
 THE NITROGEN ATOM OF THE INDOLE RING, WHETHER OR NOT FURTHER SUBSTITUTED
 ON THE INDOLE RING TO ANY EXTENT, WHETHER  OR  NOT  SUBSTITUTED  ON  THE
 NAPHTHOYL OR NAPHTHYL RING TO ANY EXTENT.
 (III)  3-(1-NAPHTHOYL)PYRROLE  BY SUBSTITUTION AT THE NITROGEN ATOM OF
 THE PYRROLE RING, WHETHER OR NOT FURTHER SUBSTITUTED IN THE INDOLE  RING
 TO  ANY  EXTENT, WHETHER OR NOT SUBSTITUTED ON THE NAPHTHOYL RING TO ANY
 EXTENT.
 (IV) 1-(1-NAPHTHYLMETHYL)INDENE BY SUBSTITUTION OF THE  3-POSITION  OF
 THE  INDENE  RING, WHETHER OR NOT FURTHER SUBSTITUTED IN THE INDENE RING
 TO ANY EXTENT, WHETHER OR NOT SUBSTITUTED ON THE NAPHTHYL  RING  TO  ANY
 EXTENT.
 (V)  3-PHENYLACETYLINDOLE  OR  3-BENZOYLINDOLE  BY SUBSTITUTION AT THE
 NITROGEN ATOM OF THE INDOLE RING, WHETHER OR NOT FURTHER SUBSTITUTED  IN
 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD15220-02-2
 
       A. 9855                             2
 THE  INDOLE RING TO ANY EXTENT, WHETHER OR NOT SUBSTITUTED ON THE PHENYL
 RING TO ANY EXTENT.
 (2)      5-(1,1-DIMETHYLHEPTYL)-2-{(1R,3S)-3-HYDROXYCYCLOHEXYL}-PHENOL
 (CP-47,497).
 (3)       5-(1,1-DIMETHYLOCTYL)-2-{(1R,3S)-3-HYDROXYCYCLOHEXYL}-PHENOL
 (CANNABICYCLOHEXANOL OR CP-47,497 C8-HOMOLOG).
 (4) 1-PENTYL-3-(1-NAPHTHOYL)INDOLE (JWH-018 AND AM678).
 (5) 1-BUTYL-3-(1-NAPHTHOYL)INDOLE (JWH-073).
 (6) 1-HEXYL-3-(1-NAPHTHOYL)INDOLE (JWH-019).
 (7) 1-{2-(4-MORPHOLINYL)ETHYL}-3-(1-NAPHTHOYL)INDOLE (JWH-200).
 (8) 1-PENTYL-3-(2-METHOXYPHENYLACETYL)INDOLE (JWH-250).
 (9) 1-PENTYL-3-{1-(4-METHOXYNAPHTHOYL)}INDOLE (JWH-081).
 (10) 1-PENTYL-3-(4-METHYL-1-NAPHTHOYL)INDOLE (JWH-122).
 (11) 1-PENTYL-3-(4-CHLORO-1-NAPHTHOYL)INDOLE (JWH-398).
 (12) 1-(5-FLUOROPENTYL)-3-(1-NAPHTHOYL)INDOLE (AM2201).
 (13) 1-(5-FLUOROPENTYL)-3-(2-IODOBENZOYL)INDOLE (AM694).
 (14) 1-PENTYL-3-{(4-METHOXY-BENZOYL}INDOLE (SR-19 AND RCS-4).
 (15)   1-CYCLOHEXYLETHYL-3-(2-METHOXYPHENYLACETYL)INDOLE   (SR-18  AND
 RCS-8).
 (16) 1-PENTYL-3-(2-CHLOROPHENYLACETYL)INDOLE (JWH-203).
 

S 2. This act shall take effect immediately.

*By contributing or voting you agree to the Terms of Participation and Privacy Policy and verify you are over 13.

Discuss!